-
Way too soon for a headline to suggest that an Aloe Vera compound may help treat Alzheimer Disease based only on computer modelling.
Medical Mythbusting Commentary for March 5, 2026 Source:Aloe Vera Compound May Help Fight Alzheimer’s Disease, Simulations Suggest Reference:In silico exploration of Aloe vera leaf compounds as dual AChE and BChE inhibitors for Alzheimer’s disease therapy
-
Mouse-model study shows Alzheimer’s may be reversible in advanced stages. Human trials required to determine if this is transferable to people.
Medical Mythbusting Commentary for January 21, 2026 Source:Groundbreaking study shows Alzheimer’s may be reversible in advanced stages Reference:Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain
-
Lithium deficiency linked to cognitive decline in mouse model and may be linked to the the disease process that leads to Alzheimer’s
Medical Mythbusting Commentary for August 28, 2025 Source:Scientists say it may be possible to protect aging brains from Alzheimer’s with an old remedy — lithium Reference:Lithium deficiency and the onset of Alzheimer’s disease
-
Can this nasal spray slow down Alzheimer’s? There is no answer when your study includes only one person.
Medical Mythbusting Commentary for June 23, 2025 Source:Can this nasal spray slow down Alzheimer’s? One couple is helping scientists find out Reference:Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia
-
Blocking Brain Inflammation Molecule May Halt Alzheimer’s
Medical Mythbusting Commentary for June 4, 2025 Source: Blocking Brain Inflammation Molecule May Halt Alzheimer’s Reference: STING deletion protects against amyloid β–induced Alzheimer’s disease pathogenesis
-
A challenge to the hypothesis explaining the pathophysiology of Alzheimer’s Disease.
Medical Mythbusting Commentary for December 11, 2024 Source:Neuroscientists just turned a major Alzheimer’s theory on its head Reference:Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer’s disease trials
-
For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease
Medical Mythbusting Commentary for May 8, 2024 Source:For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease
-
Rare cases of possible Alzheimer’s transmission uncovered in recipients of discontinued cadaver-based growth hormone treatments
Medical Mythbusting Commentary for January 31, 2024 Source:Rare cases of possible Alzheimer’s transmission uncovered in recipients of discontinued medical treatment Reference:Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone